JP2024508969A5 - - Google Patents

Info

Publication number
JP2024508969A5
JP2024508969A5 JP2023554812A JP2023554812A JP2024508969A5 JP 2024508969 A5 JP2024508969 A5 JP 2024508969A5 JP 2023554812 A JP2023554812 A JP 2023554812A JP 2023554812 A JP2023554812 A JP 2023554812A JP 2024508969 A5 JP2024508969 A5 JP 2024508969A5
Authority
JP
Japan
Prior art keywords
repeat domain
ankyrin repeat
human
binding specificity
binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023554812A
Other languages
English (en)
Japanese (ja)
Other versions
JP7869804B2 (ja
JP2024508969A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2022/052120 external-priority patent/WO2022190010A1/en
Publication of JP2024508969A publication Critical patent/JP2024508969A/ja
Publication of JP2024508969A5 publication Critical patent/JP2024508969A5/ja
Application granted granted Critical
Publication of JP7869804B2 publication Critical patent/JP7869804B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023554812A 2021-03-09 2022-03-09 新規のDARPinに基づくCD33エンゲージャ Active JP7869804B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202163158539P 2021-03-09 2021-03-09
US63/158,539 2021-03-09
US202163172818P 2021-04-09 2021-04-09
US63/172,818 2021-04-09
US202163265179P 2021-12-09 2021-12-09
US63/265,179 2021-12-09
PCT/IB2022/052120 WO2022190010A1 (en) 2021-03-09 2022-03-09 Novel darpin based cd33 engagers

Publications (3)

Publication Number Publication Date
JP2024508969A JP2024508969A (ja) 2024-02-28
JP2024508969A5 true JP2024508969A5 (cg-RX-API-DMAC7.html) 2025-03-18
JP7869804B2 JP7869804B2 (ja) 2026-06-03

Family

ID=80933410

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023554812A Active JP7869804B2 (ja) 2021-03-09 2022-03-09 新規のDARPinに基づくCD33エンゲージャ

Country Status (6)

Country Link
US (1) US20240317852A1 (cg-RX-API-DMAC7.html)
EP (1) EP4304730A1 (cg-RX-API-DMAC7.html)
JP (1) JP7869804B2 (cg-RX-API-DMAC7.html)
AU (1) AU2022231913A1 (cg-RX-API-DMAC7.html)
CA (1) CA3211248A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022190010A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL298168A (en) 2020-05-14 2023-01-01 Molecular Partners Ag Multispecific proteins
WO2022190016A1 (en) 2021-03-09 2022-09-15 Molecular Partners Ag Novel darpin based multi-specific t-cell engagers
WO2024251628A1 (en) * 2023-06-06 2024-12-12 Molecular Partners Ag Recombinant cd16a binding proteins and their use
WO2025163082A1 (en) * 2024-01-31 2025-08-07 Molecular Partners Ag Dll3-specific binding constructs and their use in radiotherapy
WO2025181039A1 (en) 2024-03-01 2025-09-04 Molecular Partners Ag Therapeutic combinations comprising a multi-specific t cell engager

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9400088D0 (sv) 1994-01-14 1994-01-14 Kabi Pharmacia Ab Bacterial receptor structures
US6818418B1 (en) 1998-12-10 2004-11-16 Compound Therapeutics, Inc. Protein scaffolds for antibody mimics and other binding proteins
EP1332209B1 (en) 2000-09-08 2009-11-11 Universität Zürich Collections of repeat proteins comprising repeat modules
US20050048512A1 (en) 2001-04-26 2005-03-03 Avidia Research Institute Combinatorial libraries of monomer domains
US20040175756A1 (en) 2001-04-26 2004-09-09 Avidia Research Institute Methods for using combinatorial libraries of monomer domains
US20050053973A1 (en) 2001-04-26 2005-03-10 Avidia Research Institute Novel proteins with targeted binding
WO2005063815A2 (en) 2003-11-12 2005-07-14 Biogen Idec Ma Inc. Fcϝ receptor-binding polypeptide variants and methods related thereto
US20060008844A1 (en) 2004-06-17 2006-01-12 Avidia Research Institute c-Met kinase binding proteins
CA2700391A1 (en) 2007-09-24 2009-04-02 University Of Zuerich Designed armadillo repeat proteins
NZ592591A (en) 2008-11-03 2012-04-27 Molecular Partners Ag Binding proteins comprising ankyrin repeast domains that inhibit the vegf-a receptor interaction
EP2332994A1 (en) 2009-12-09 2011-06-15 Friedrich-Alexander-Universität Erlangen-Nürnberg Trispecific therapeutics against acute myeloid leukaemia
TWI510246B (zh) 2010-04-30 2015-12-01 Molecular Partners Ag 抑制vegf-a受體交互作用的經修飾結合性蛋白質
EP3514169B1 (en) 2010-11-26 2024-03-06 Molecular Partners AG Designed repeat proteins binding to serum albumin
SG11201408196RA (en) 2012-06-28 2015-03-30 Molecular Partners Ag Designed ankyrin repeat proteins binding to platelet-derived growth factor
EP2738180A1 (en) 2012-11-30 2014-06-04 Molecular Partners AG Binding proteins comprising at least two binding domains against HER2.
EP2789630A1 (en) 2013-04-09 2014-10-15 EngMab AG Bispecific antibodies against CD3e and ROR1
US11453708B2 (en) 2013-05-31 2022-09-27 Molecular Partners Ag Designed ankyrin repeat proteins binding to hepatocyte growth factor
US9458211B1 (en) 2015-04-02 2016-10-04 Molecular Partners Ag Recombinant proteins that simultaneously bind HGF, VEGF-A and serum albumin, comprising ankyrin repeat domains
MY196882A (en) 2016-09-22 2023-05-08 Molecular Partners Ag Recombinant binding proteins and their use

Similar Documents

Publication Publication Date Title
JP2024513559A5 (cg-RX-API-DMAC7.html)
JP2024509904A5 (cg-RX-API-DMAC7.html)
JP2016052315A5 (cg-RX-API-DMAC7.html)
JP2019531093A5 (cg-RX-API-DMAC7.html)
JP2023506765A5 (cg-RX-API-DMAC7.html)
JP2025137626A5 (cg-RX-API-DMAC7.html)
JP2021502810A5 (cg-RX-API-DMAC7.html)
JP2021521822A5 (cg-RX-API-DMAC7.html)
JP2022527635A5 (cg-RX-API-DMAC7.html)
JP2020508691A5 (cg-RX-API-DMAC7.html)
JP2023528204A5 (cg-RX-API-DMAC7.html)
JP2018521640A5 (cg-RX-API-DMAC7.html)
JP2019511201A5 (cg-RX-API-DMAC7.html)
WO2021092075A1 (en) IL-2RβγC BINDING COMPOUNDS
JP2023553697A5 (cg-RX-API-DMAC7.html)
JP2016516061A5 (cg-RX-API-DMAC7.html)
CA2561826A1 (en) Linear single chain recombinant anti-cea/cd3/cd28 trispecific antibody
JP2023554379A5 (cg-RX-API-DMAC7.html)
CN115003689A (zh) 具有改变的表面残基的经设计的锚蛋白重复结构域
JP2020530285A5 (cg-RX-API-DMAC7.html)
JP2022524338A5 (cg-RX-API-DMAC7.html)
JP2023528207A5 (cg-RX-API-DMAC7.html)
CN105142663A (zh) 用于癌症靶向治疗的含有结合白蛋白的精氨酸脱亚胺酶的药物组合物
JP2024508683A5 (cg-RX-API-DMAC7.html)
JP2016531583A5 (cg-RX-API-DMAC7.html)